AKT1 and cancer: Rapalogs can also cause activation of AKT through disruption of a negative feedback loop on the mTORC2 complex, which is involved in cancer cell growth and survival: this limitation led to development of a second generation of mTOR inhibitors, which are ATP-competitive mTOR kinase inhibitors [179].